Vitiligo Treatment by Targeting TYK2 Mediated Responses

Conditions: Vitiligo, Generalized Interventions: Drug: Deucravacitinib; Other: Volunteer without treatment Sponsors: Centre Hospitalier Universitaire de Nice Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials